Versant Capital Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,570
Closed -$33K 1718
2022
Q3
$33K Buy
1,570
+555
+55% +$11.6K 0.01% 303
2022
Q2
$21K Buy
1,015
+33
+3% +$587 0.01% 427
2022
Q1
$16K Buy
982
+49
+5% +$857 0.01% 551
2021
Q4
$19K Hold
933
0.01% 525
2021
Q3
$17K Hold
933
0.01% 538
2021
Q2
$25K Sell
933
-1,461
-61% -$40.9K 0.01% 412
2021
Q1
$72K Sell
2,394
-123
-5% -$4.19K 0.03% 191
2020
Q4
$72K Sell
2,517
-101
-4% -$2.73K 0.03% 174
2020
Q3
$63K Sell
2,618
-82
-3% -$1.77K 0.03% 183
2020
Q2
$48K Sell
2,700
-126
-4% -$1.66K 0.02% 217
2020
Q1
$23K Buy
2,826
+2,806
+14,030% +$32.1K 0.01% 336
2019
Q4
$0 Sell
20
-2
-9% -$24 ﹤0.01% 1661
2019
Q3
$0 Hold
22
﹤0.01% 1665
2019
Q2
$0 Buy
+22
New +$634 ﹤0.01% 1800

Other funds holding CVET

Versant Capital Management's CVET Position: Q4 2022 in Review

Versant Capital Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,570 shares — an estimated $33K sold.

Versant Capital Management first reported a position in CVET in Q2 2019 and held it in 14 quarters. The position peaked at $72K in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Versant Capital Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Versant Capital Management sold 1,570 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $33K.
  • Versant Capital Management first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Versant Capital Management's Covetrus, Inc. Common Stock position peaked at $72K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Versant Capital Management's 13F filing for Q4 2022, filed 25 Jan 2023.